Hepatitis A virus immunity and seroconversion among contacts of acute hepatitis A patients in Amsterdam, 1996-2000: An evaluation of current prevention policy

American Journal of Public Health

Volumn 94, Issue 9, 2004, Pages 1620-1626

  Sonder, Gerard J B ^a,b   Van Steenbergen, Jim E ^a,c   Bovee, Lian P M J ^a   Peerbooms, Paul G H ^a   Coutinho, Roel A ^a,d   Van Den Hoek, Anneke ^a  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b LCR   (Netherlands)

^c LCI   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; EVALUATION; FEMALE; HEALTH CARE POLICY; HEPATITIS A; HEPATITIS A VIRUS; HOUSEHOLD; HUMAN; HYGIENE; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOMES RESEARCH; PASSIVE IMMUNIZATION; SEROCONVERSION; SEXUALITY; SUPERINFECTION; SYMPTOMATOLOGY; VIRUS IMMUNITY; VIRUS TRANSMISSION;

EID: 4344658257     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.9.1620     Document Type: Article

References (19)

1. Termorshiuzen F, Dorigo-Zetsma JW, De Melker HE, van den Hof S, Conyn-van Spaendonck MAE. The prevalence of antibodies to hepatitis A virus and its determinants in the Netherlands: a population-based survey. Epidemiol Infect. 2000;124:459-466.
2. Gorkom J van, Leentvaar-Kuijpers A, Kool JL, Coutinho RA. [Association between the yearly hepatitis A epidemic and travel behaviour of children of immigrants in the four major cities of the Netherlands.] Ned Tijdschr Geneesk. 1998;34:1919-1923.
3. Coutinho RA, Albrecht-van Lent P, Lelie N, Nagelkerke N, Kuipers H, Rijsdijk T. Prevalence and incidence of hepatitis A among male homosexuals. BMJ. 1983;287:1743-1745.
4. Leentvaar-Kuijpers A, Kool JL, Veugelers PJ, Coutinho RA, van Griensven GJ. [An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993.] Int J Epidemiol. 1995;24:218-22.
5. Bruisten SM, van Steenbergen JE, Fijl AS, et al. Molecular epidemiology of hepatitis A virus in Amsterdam, Netherlands. J Med Virol 2001;63:88-95.
6. Ascertainment of secondary cases of hepatitis A-Kansas, 1996-1997 [editorial]. MMWR Morb Mortal Wkly Rep. 1999;48:608-610, 619.
7. van Steenbergen JE, Tjon G, van den Hoek JAR, Koek A, Coutinho RA, Bruisten SM. Two years prospective collection of molecular and epidemiological data shows limited spread of hepatitis A outside risk groups in Amsterdam 2000-2002. J Infect Dis. 2004;189:471-482.
8. Dijkshoorn H, Schilthuis HJ, van den Hoek JAR, Verhoeff AP. [Travel advice on the prevention of infectious diseases insufficiently obtained by indigenous and non-native inhabitants of Amsterdam, the Netherlands.] Ned Tijdschr Geneeskd. 2003;147:658-662.
9. Bovėe LPMJ, van den Hoek JAR. Annual Report 2002, Department of Infectious Diseases, GG&GD Amsterdam. Amsterdam, the Netherlands: GG&GD Amsterdam; 2003:15.
10. Gingrich GA, Hadler SC, Elder HA, Ash KO. Serologic investigation of an outbreak of hepatitis A in a rural day-care center. Am J Public Health. 1983;73:1190-1193.
11. Rameliotou A, Papachristopoulos A, Alexiou D, Papaevangelou V, Stergiou G, Papaevangelou G. Intrafamilial clustering of hepatitis A. Infection. 1994;22:36-38.
12. Sagliocca L, Amoroso P, Stroffolini T, et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: a randomized trial. Lancet. 1999;353:1136-1139.
13. Meyerhoff AS. Jacobs RJ. Transmission of hepatitis A through household contact. J Viral Hepatitis. 2001;8:454-458.
14. Mutton KJ, Gust ID. Public health aspects of hepatitis A. In: Gerety RJ, ed. Hepatitis A. Orlando, Fla: Academic Press; 1984:152.
15. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR-12):1-37.
16. Hadler SC, Erben JJ, Matthews D, Starko K, Francis DP, Maynard JE. Effect of immunoglobulin on Hepatitis A in day-care centers. JAMA. 1983;248:48-53.
17. LCI. Hepatitis A. In: van Steenbergen JE, Timen A, eds. LCI Guidelines Communicable Disease Control. Utrecht, The Netherlands: Landelijke Coördinatie van Infectieziekten Nederland (LCI); 2003. In press.
18. Reuman PD, Kubilis P, Hurni W, Brown L, Nalin D. The effect of age and weight on the response to formalin-inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults. Vaccine. 1997;15:1157-1161.
19. Conaty S. Continued role for HNIG in hepatitis A post-exposure prophylaxis [letter]. Comm Dis Public Health. 2001;4:319.